Differential gene expression profiles of human leukemia cell lines exposed to benzene and its metabolites

Environmental Toxicology and Pharmacology

Volumn 32, Issue 2, 2011, Pages 285-295

  Sarma, Sailendra Nath ^a,b   Kim, Youn Jung ^c   Ryu, Jae Chun ^a  

^a Korea Institute of Science and Technology   (South Korea)

^b Dongguk University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Benzene; Benzoquinone; Gene expression profiles; Human leukemia cell; Hydroquinone

Indexed keywords

1,4 BENZOQUINONE; BENZENE; BIOLOGICAL MARKER; HYDROQUINONE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; T LYMPHOCYTE RECEPTOR;

ANDROGEN RECEPTOR GENE; APOPTOSIS; ARTICLE; CD69 MOLECULE GENE; CELL CYCLE REGULATION; CELL STRAIN HL 60; CELL STRAIN K 562; CELL STRAIN U937; CELL VIABILITY; CHEMOKINE LIGAND 2 GENE; CONTROLLED STUDY; CYTOTOXICITY TEST; DNA MICROARRAY; EARLY GROWTH RESPONSE 1 GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ASSOCIATION; HEAT SHOCK 70 KDA PROTEIN 8 GENE; HOMOCYSTEINE INDUCIBLE ENDOPLASMIC RETICULUM STRESS INDUCIBLE UBIQUITIN LIKE DOMAIN MEMBER 1 GENE; HUMAN; HUMAN CELL; HUMAN GENOME; LEUKEMOGENESIS; METABOLITE; MONOCLONAL ANTIBODY KI 67 GENE; NUCLEOTIDE SEQUENCE; PHORBOL 12 MYRISTATE 13 ACETATE INDUCED PROTEIN 1 GENE; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SOLUTE CARRIER FAMILY 7 MEMBER 11 GENE; TUMOR GENE;

BENZENE; BENZOQUINONES; BIOLOGICAL MARKERS; CLUSTER ANALYSIS; ENVIRONMENTAL POLLUTANTS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HL-60 CELLS; HUMANS; HYDROQUINONES; K562 CELLS; LEUKEMIA; MICROARRAY ANALYSIS; SIGNAL TRANSDUCTION; U937 CELLS;

EID: 80051672855     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2011.06.001     Document Type: Article

References (42)

1. Albers P., Orazi A., Ulbright T.M., Miller G.A., Haidar J.H., Donohue J.P., Foster R.S. Prognostic significance of immunohistochemical proliferation markers (Ki-67/MIB-1 and proliferation-associated nuclear antigen), p53 protein accumulation, and neovascularization in clinical stage A nonseminomatous testicular germ cell tumors. Mod. Pathol. 1995, 8:492-497.
2. Andrade A.A., Silva P.N.G., Pereira A.C.T.C., De Sousa L.P., Ferreira P.C.P., Gazzinelli R.T., Kroon E.G., Ropert C., Bonjardim C.A. The vaccinia virus-stimulated mitogen-activated protein kinase (MAPK) pathway is required for virus multiplication. Biochem. J. 2004, 381:437-446.
3. Baron V., Adamson E.D., Calogero A., Ragona G., Mercola D. The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther. 2006, 13:115-124.
4. Cambiaggi C., Scupoli M.T., Cestari T., Gerosa F., Carra G., Tridente G., Accolla R.S. Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12. Immunogenetics 1992, 36:117-120.
5. Cesari F., Brecht S., Vintersten K., Vuong L.G., Hofmann M., Klingel K., Schnorr J.J., Arsenian S., Schild H., Herdegen T., Wiebel F.F., Nordheim A. Mice deficient for the ets transcription factor elk-1 show normal immune responses and mildly impaired neuronal gene activation. Mol. Cell Biol. 2004, 24:294-305.
6. Chong K.Y., Lai C.C., Lille S., Chang C., Su C.Y. Stable overexpression of the constitutive form of heat shock protein 70 confers oxidative protection. J. Mol. Cell Cardiol. 1998, 30:599-608.
7. D'Antonio J.M., Vander Griend D.J., Antony L., Ndikuyeze G., Dalrymple S.L., Koochekpour S., Isaacs J.T. Loss of androgen receptor-dependent growth suppression by prostate cancer cells can occur independently from acquiring oncogenic addiction to androgen receptor signaling. PLoS One 2010, 5:e11475.
8. De Marzo A.M., Platz E.A., Sutcliffe S., Xu J., Gronberg H., Drake C.G., Nakai Y., Isaacs W.B., Nelson W.G. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer 2007, 7:256-269.
9. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30:207-210.
10. Egeghy P.P., Tornero-Velez R., Rappaport S.M. Environmental and biological monitoring of benzene during self-service automobile refueling. Environ. Health Perspect. 2000, 108:1195-1202.
11. IARC IARC Monographs on the Evaluation of Carcinogenic Risk to Humans, Supplement 7 1987, Vol. 1-42. World Health Organization, Lyon.
12. Inayat-Hussain S.H., Ibrahim H.A., Siew E.L., Rajab N.F., Chan K.M., Williams G.T., Ross D. Modulation of the benzene metabolite hydroquinone induced toxicity: evidence for an important role of fau. Chem. Biol. Interact. 2010, 184:310-312.
13. Gabai V.L., Mabuchi K., Mosser D.D., Sherman M.Y. Hsp72 and stress kinase c-jun N-terminal kinase regulate the bid-dependent pathway in tumor necrosis factor-induced apoptosis. Mol. Cell Biol. 2002, 22:3415-3424.
14. Hazel B.A., Baum C., Kalf G.F. Hydroquinone, a bioreactive metabolite of benzene, inhibits apoptosis in myeloblasts. Stem Cells 1996, 14:730-742.
15. Hassan M., Alaoui A., Feyen O., Mirmohammadsadegh A., Essmann F., Tannapfel A., Gulbins E., Schulze-Osthoff K., Hengge U.R. The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways. Oncogene 2008, 27:4557-4568.
16. Hutt A.M., Kalf G.F. Inhibition of human DNA topoisomerase II by hydroquinone and p-benzoquinone, reactive metabolites of benzene. Environ. Health Perspect. 1996, 104(Suppl. 6):1265-1269.
17. Kanehisa M., Goto S., Hattori M., Aoki-Kinoshita K.F., Itoh M., Kawashima S., Katayama T., Araki M., Hirakawa M. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 2006, 34:D354-357.
18. Kodiha M., Chu A., Lazrak O., Stochaj U. Stress inhibits nucleocytoplasmic shuttling of heat shock protein hsc70. Am. J. Physiol. Cell Physiol. 2005, 289:C1034-C1041.
19. Lee J.I., Dominy J.E., Sikalidis A.K., Hirschberger L.L., Wang W., Stipanuk M.H. HepG2/C3A cells respond to cysteine deprivation by induction of the amino acid deprivation/integrated stress response pathway. Physiol. Genomics 2008, 33:218-229.
20. Liang Y.X., Wong O., Armstrong T., Ye X.B., Miao L.Z., Zhou Y.M., Wu Q.E., Qian H.J., Fu H. An overview of published benzene exposure data by industry in China, 1960-2003. Chem. Biol. Interact. 2005, 153-154:55-64.
21. Lindsey R.H., Bromberg K.D., Felix C.A., Osheroff N. 1,4-Benzoquinone is a topoisomerase II poison. Biochemistry 2004, 43:7563-7574.
22. Loberg R.D., Ying C., Craig M., Yan L., Snyder L.A., Pienta K.J. CCL2 as an important mediator of prostate cancer growth in vivo through the regulation of macrophage infiltration. Neoplasia 2007, 9:556-562.
23. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65:55-63.
24. Mosser D.D., Morimoto R.I. Molecular chaperones and the stress of oncogenesis. Oncogene 2004, 23:2907-2918.
25. + human bone marrow progenitor cells. Mol. Pharmacol. 1996, 50:610-615.
26. Moretti L., Cha Y.I., Niermann K.J., Lu B. Switch between apoptosis and autophagy: radiation-induced endoplasmic reticulum stress?. Cell Cycle 2007, 6:793-798.
27. Park H.W., Kim S.J., An Y.R., Kim J.S., Yu S.Y., Oh M.J., Kim Y.J., Ryu J.C., Hwang S.Y. Gene expression profiling of HepG2 cells treated with endocrine disrupting chemicals using the HazChem human array V3. Mol. Cell. Toxicol. 2010, 6:57-63.
28. Pawlinski R., Pedersen B., Kehrle B., Aird W.C., Frank R.D., Guha M., Mackman N. Regulation of tissue factor and inflammatory mediators by Egr-1 in a mouse endotoxemia model. Blood 2003, 101:3940-3947.
29. Sai X., Kawamura Y., Kokame K., Yamaguchi H., Shiraishi H., Suzuki R., Suzuki T., Kawaichi M., Miyata T., Kitamura T., De Strooper B., Yanagisawa K., Komano H. Endoplasmic reticulum stress-inducible protein, Herp, enhances presenilin-mediated generation of amyloid beta-protein. J. Biol. Chem. 2002, 277:12915-12920.
30. Sarma S.N., Kim Y.J., Ryu J.C. Differential gene expression profiling in human promyelocytic leukemia cells treated with benzene and ethylbenzene. Mol. Cell. Toxicol. 2008, 4:267-277.
31. Sarma S.N., Kim Y.J., Ryu J.C. Gene expression profiles of human promyelocytic leukemia cell lines exposed to volatile organic compounds. Toxicology 2010, 271:122-130.
32. Shen M., Zhang L.P., Bonner M.R., Liu C.S., Li G.L., Vermeulen R., Dosemeci M., Yin S.N., Lan Q. Association between mitochondrial DNA copy number, blood cell counts, and occupational benzene exposure. Environ. Mol. Mutagen. 2008, 49:453-457.
33. Smith M.T The mechanism of benzene-induced leukemia: a hypothesis and speculations on the causes of leukemia. Environ. Health Perspect. 1996, 104(Suppl. 6):1219-1225.
34. Snyder R. Benzene and leukemia. Crit. Rev. Toxicol. 2002, 32:155-210.
35. Snyder R. Xenobiotic metabolism and the mechanism(s) of benzene toxicity. Drug Metab. Rev. 2004, 36:531-547.
36. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., Paulovich A., Pomeroy S.L., Golub T.R., Lander E.S., Mesirov J.P. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:15545-15550.
37. Thiel G., Cibelli G. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell Physiol. 2002, 193:287-292.
38. Tusher V.G., Tibshirani R., Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:5116-5121.
39. Whitmarsh A.J., Shore P., Sharrocks A.D., Davis R.J. Integration of MAP kinase signal transduction pathways at the serum response element. Science 1995, 269:403-407.
40. Winn L.M. Homologous recombination initiated by benzene metabolites: a potential role of oxidative stress. Toxicol. Sci. 2003, 72:143-149.
41. Yang S.Z., Abdulkadir S.A. Early growth response gene 1 modulates androgen receptor signaling in prostate carcinoma cells. J. Biol. Chem. 2003, 278:39906-39911.
42. Zhao Z., He X., Bi Y., Xia Y., Tao N., Li L., Ma Q. Induction of CYP4F3 by benzene metabolites in human white blood cells in vivo in human promyelocytic leukemic cell lines and ex vivo in human blood neutrophils. Drug. Metab. Dispos. 2009, 37:282-291.